Daryll Vanover News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs. With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19. Best of all, the treatment could be delivered to the lungs via a nebulizer, making it easy for patients to administer themselves at home. The therapy is based on a type of CRISPR, which normally allows researchers to target and edit specific porti...

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.

Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections March 5, 2021 If you think breathing in gene editing enzymes to treat infectious diseases, such as the flu or COVID-19, is a technology that is far-fetched or a long way off, think again. A team of investigators from the Georgia Institute of Technology and Emory University has developed a CRISPR-based treatment to stop the replication of both the flu virus and the virus that causes COVID-19 in mice. Moreover, the new treatment is delivered to the lungs via a nebulizer, which could make it simple for patients to administer th...

The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.